Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26730 | 247 | 23.9 | 34% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
1459 | 2 | BENZODIAZEPINES//ZOLPIDEM//ZOPICLONE | 7774 |
26730 | 1 | TRIMELAMOL//N HYDROXYMETHYLMELAMINES//HEXAMETHYLMELAMINE | 247 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRIMELAMOL | authKW | 494499 | 2% | 100% | 4 |
2 | N HYDROXYMETHYLMELAMINES | authKW | 247250 | 1% | 100% | 2 |
3 | HEXAMETHYLMELAMINE | authKW | 164828 | 2% | 33% | 4 |
4 | 2 4 6 TRISDIMETHYLAMINO 1 3 5 TRIAZINE | authKW | 123625 | 0% | 100% | 1 |
5 | ALKYLATING AGENT PLATINUM RESISTANCE | authKW | 123625 | 0% | 100% | 1 |
6 | CHEM BIOL ACT SUBSTANCES | address | 123625 | 0% | 100% | 1 |
7 | CUCURBITINE | authKW | 123625 | 0% | 100% | 1 |
8 | DESENSITISATION DEACTIVATION | authKW | 123625 | 0% | 100% | 1 |
9 | HEXAMETHYLMELAMINE DERIVATIVE | authKW | 123625 | 0% | 100% | 1 |
10 | HYDROXYMETHYLPENTAMETHYLMELAMINE | authKW | 123625 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1895 | 51% | 0% | 126 |
2 | Oncology | 564 | 26% | 0% | 64 |
3 | Chemistry, Medicinal | 212 | 9% | 0% | 23 |
4 | Chemistry, Multidisciplinary | 46 | 12% | 0% | 29 |
5 | Chemistry, Organic | 45 | 8% | 0% | 19 |
6 | Toxicology | 30 | 4% | 0% | 10 |
7 | Chemistry, Analytical | 19 | 5% | 0% | 13 |
8 | Biochemical Research Methods | 4 | 2% | 0% | 6 |
9 | Medicine, Research & Experimental | 4 | 3% | 0% | 7 |
10 | Spectroscopy | 3 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEM BIOL ACT SUBSTANCES | 123625 | 0% | 100% | 1 |
2 | PHARM PHARMACOL PHARMACOTHER Y | 123625 | 0% | 100% | 1 |
3 | SYNTH MED PREPARAT PHIL 5 | 123625 | 0% | 100% | 1 |
4 | SHIONOGI FUKUSHIMA KU | 10088 | 1% | 4% | 2 |
5 | CELLULAR MEMBRANOL | 2167 | 0% | 2% | 1 |
6 | CHEM PHYS PROBLEMS | 642 | 0% | 1% | 1 |
7 | BIOL ZOOL | 233 | 0% | 0% | 1 |
8 | MOL CRYSTAL ENGN | 216 | 0% | 0% | 1 |
9 | PHARMACOKINET DYNAM METAB | 140 | 0% | 0% | 1 |
10 | AFFILIATED HOSP 4 | 61 | 0% | 0% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER TREATMENT REPORTS | 18171 | 7% | 1% | 18 |
2 | FOLIA PHARMACOLOGICA JAPONICA | 9102 | 4% | 1% | 9 |
3 | KHIMIKO-FARMATSEVTICHESKII ZHURNAL | 4824 | 4% | 0% | 10 |
4 | JOURNAL OF PHARMACOBIO-DYNAMICS | 3709 | 3% | 0% | 7 |
5 | PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 1949 | 1% | 1% | 3 |
6 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1673 | 4% | 0% | 10 |
7 | JAPANESE JOURNAL OF PHARMACOLOGY | 1374 | 3% | 0% | 7 |
8 | BIOCHEMICAL PHARMACOLOGY | 1297 | 6% | 0% | 14 |
9 | CRC CRITICAL REVIEWS IN TOXICOLOGY | 1046 | 0% | 1% | 1 |
10 | JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY | 1037 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DAMIA, G , DINCALCI, M , (1995) CLINICAL PHARMACOKINETICS OF ALTRETAMINE.CLINICAL PHARMACOKINETICS. VOL. 28. ISSUE 6. P. 439-448 | 30 | 91% | 8 |
2 | DINCALCI, M , (1987) METABOLISM OF TRIAZINE ANTICANCER AGENTS.PHARMACOLOGY & THERAPEUTICS. VOL. 35. ISSUE 3. P. 291-300 | 31 | 97% | 5 |
3 | COLEY, HM , (1997) N-(HYDROXYMETHYL) MELAMINES.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 28. ISSUE 2. P. 177-182 | 18 | 95% | 8 |
4 | AMES, MM , (1991) HEXAMETHYLMELAMINE - PHARMACOLOGY AND MECHANISM OF ACTION.CANCER TREATMENT REVIEWS. VOL. 18. ISSUE . P. 3-14 | 22 | 92% | 17 |
5 | DUBOIS, J , ATASSI, G , HANOCQ, M , ABIKHALIL, F , (1988) PHARMACOKINETICS AND METABOLISM OF HEXAMETHYLMELAMINE IN MICE BEARING RENAL-CELL TUMORS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 22. ISSUE 4. P. 282-288 | 20 | 100% | 2 |
6 | FOSTER, BJ , CLAGETTCARR, K , HOTH, D , LEYLANDJONES, B , (1986) PENTAMETHYLMELAMINE - REVIEW OF AN AQUEOUS ANALOG OF HEXAMETHYLMELAMINE.CANCER TREATMENT REPORTS. VOL. 70. ISSUE 3. P. 383-389 | 19 | 100% | 6 |
7 | DUBOIS, J , ATASSI, G , HANOCQ, M , ABIKHALIL, F , (1989) TUMOR PHARMACOKINETICS OF HEXAMETHYLMELAMINE IN CDF1 MICE BEARING P388 LEUKEMIA.ANTICANCER RESEARCH. VOL. 9. ISSUE 1. P. 255-259 | 13 | 100% | 2 |
8 | COLEY, HM , JARMAN, M , BROOKS, N , KUBOTA, T , GODDARD, PM , JONES, M , LEE, N , OWENS, MD , HALBERT, GW , JUDSON, IR , (1996) PRE-CLINICAL DEVELOPMENT OF THE ANTI-TUMOUR AGENT CB 7646, BIS N-(HYDROXYMETHYL) TRIMETHYLMELAMINE, A STABLE ANALOGUE OF TRIMELAMOL.INTERNATIONAL JOURNAL OF CANCER. VOL. 68. ISSUE 3. P. 356-363 | 11 | 65% | 1 |
9 | AMES, MM , RICHARDSON, RL , KOVACH, JS , MOERTEL, CG , OCONNELL, MJ , (1990) PHASE-I AND CLINICAL PHARMACOLOGICAL EVALUATION OF A PARENTERAL HEXAMETHYLMELAMINE FORMULATION.CANCER RESEARCH. VOL. 50. ISSUE 1. P. 206-210 | 8 | 100% | 8 |
10 | DUBOIS, J , ARNOULD, R , ABIKHALIL, F , HANOCQ, M , ATASSI, G , GHANEM, G , LIBERT, A , LEJEUNE, FJ , (1990) INVITRO CYTOTOXICITY OF HEXAMETHYLMELAMINE (HMM) AND ITS DERIVATIVES.ANTICANCER RESEARCH. VOL. 10. ISSUE 3. P. 827-832 | 8 | 100% | 6 |
Classes with closest relation at Level 1 |